, JOrge e. tOBlli 1, 6 , BelisAriO e. ABSTRACT Background: The aim of this study was to determine the presence of alterations in the natriuretic systems of atrial natriuretic peptide and renal dopamine in a model of metabolic syndrome induced by fructose overload and to associate them with changes in systolic blood pressure, renal function, Na+/K+-ATPase status and microalbuminuria. Methods: Male Sprague-Dawley rats were divided into control (C) and fructose (F) groups receiving drinking water or a fructose solution (10% W/V), respectively, for 4, 8 and 12 weeks. L-dopa and dopamine, sodium, creatinine and albumin were measured in urine and ANP, insulin, sodium and creatinine in plasma. Systolic blood pressure was measured by indirect method and the renal activity and expression of Na+/K+-ATPase as well as the renal expression of A-and C-type natriuretic peptide receptors were assessed. results: Fructose overload was associated with a significant increase in insulinemia and systolic blood pressure levels and a decrease in urinary sodium excretion since week 4. A significant increase in L-dopa excretion and a decrease in dopamine excretion (increased urinary L-dopa/dopamine ratio) due to fructose overload were observed since week 4 with a decrease in plasma atrial natriuretic peptide at weeks 8 and 12. These changes were accompanied by increased activity and expression of Na+/ K+-ATPase, decreased A-type natriuretic peptide receptor and increased C-type natriuretic peptide receptor expression. Microalbuminuria was observed at week 12 of fructose overload. Conclusions: Altered atrial natriuretic peptide and renal dopamine were associated with the development of hypertension and preceded in time the presence of microalbuminuria, thus establishing a temporal association between the alteration of both systems and the development of renal damage.
INTRODUCTION
Hypertension is the most prevalent chronic disease with worldwide incidence and one of the cardiovascular risk factors that takes part in the definition of metabolic syndrome. (1, 2) It has been shown that altered renal excretion of sodium has vital importance in the pathogenesis of hypertension. (3) Renal dopamine and the atrial natriuretic peptide (ANP) are two natriuretic systems capable of modifying renal sodium management through the regulation of various sodium ion transporters in tubular cells. (3, 4) Among these cells, proximal tubular cells are able to synthesize dopamine from the uptake and subsequent decarboxylation of the L-dopa precursor by dopa decarboxylase. (5) Under basal conditions, more than 50% of the renal excretion of sodium is regulated by the activation of dopamine-mediated D1 receptors. (6) On the other hand, ANP exerts its natriuretic action by activating the A-type natriuretic peptide receptor (NPRA) in the kidneys. (7) The atrial natriuretic peptide can also bind to the C-type natriuretic peptide receptor (NPRC), which is considered a clearing receptor that mediates the degradation of this peptide. (8) During the last decade, numerous studies have suggested the possible existence of an interaction between natriuretic peptides and the renal dopaminergic system. (9, 10) . In this sense, it has been reported that renal dopamine and ANP can achieve their natriuretic effects through a common pathway that involves the reversible deactivation of renal Na+/ K+-ATPase, an enzyme whose alteration is closely related to saline retention. (11, 12) On the other hand, it is estimated that about 30-50% of hypertensive patients have insulin resistance.
(1, 13) Several studies have established an association between insulin resistance and alterations in the renal dopaminergic system in the genesis of hypertension. (14) It has been demonstrated that rats with insulinresistance due to fructose overload (FO) have lower urinary excretion of dopamine, which inversely correlates with blood pressure levels. (15) Likewise, several studies have confirmed a correlation between low levels of ANP and high levels of glucose and insulin, as well as of cholesterol and plasma triglycerides. (16, 17) However, there is little evidence about the interaction between renal dopamine and ANP in the physiopathology of hypertension induced by a high fructose diet. Moreover, the kidney is one of the target organs of hypertension, and microalbuminuria is currently an early indicator of nephropathy and a predictor of ischemic heart disease in essential hypertension. (18) In this context, the association between metabolic syndrome, insulin resistance and renal damage has been demonstrated. (19, 20) The aim of this work was to determine whether alterations in the natriuretic systems of ANP and renal dopamine in insulin-resistant rats due to high fructose diet are associated with changes in systolic blood pressure and renal tubular function, increased activity or expression of renal Na+/K+-ATPase and the presence of microalbuminuria as a marker of renal structural damage.
METHODS

experimental animals
Male Sprague-Dawley rats weighing 150 to 180 g were used, with 12:12 h light/dark cycles, at 22ºC, and fed with a balanced diet for rodents.
Systolic blood pressure assessment
The animals were trained three times a week in the procedure of blood pressure assessment. Systolic blood pressure (SBP) was determined before beginning the study and at the end of each experimental period through indirect plethysmographic method by means of a sphygmomanometer in the rat tail, using an inflatable cuff and a microphone connected to a Grass DC amplifier (model 7DAC, Grass Instruments Co.) coupled to a polygraph (model 79D, Grass Instruments Co.).
Collection and processing of urine and blood samples
At the end of each experimental period, 24-hour urine samples were collected from the animals housed in metabolic cages, to determine 24-hour urine output and the urinary excretion of sodium, creatinine, albumin, L-dopa and dopamine. Before sacrifice and under intraperitoneal anesthesia with ketamine (80 mg/kg) and xylazine (12 mg/kg), blood samples were collected from the retroocular plexus and centrifuged at 2700 rpm for 20 minutes at 4°C. Plasma and abbreviations Conclusiones: Las alteraciones del péptido natriurético atrial y de la dopamina renal se asociaron con el desarrollo de hipertensión arterial y precedieron a la aparición de microalbuminuria, por lo que se pudo establecer una asociación temporal entre la alteración de ambos sistemas y el desarrollo de daño renal.
urinary concentrations of sodium, creatinine and albumin were determined in an automated autoanalyzer (Spectrum CCX automated analyzer, diagnostic Abbott) by spectrophotometric method. Plasma insulin levels were determined by ELISA (Millipore Corporation) and plasma levels of ANP by ELISA (R & D Systems), after extraction by reverse phase chromatography with Sep-Pak C18 cartridges, according to the purification methodology of Sarda et al. (21) l-dopa and dopamine concentration assessment
Assessment of the urinary concentration of L-dopa and dopamine was performed by stabilization with 1 M acetic acid (pH 6.10), recovery in alumina and separation by reversedphase high-performance liquid chromatography (RP-HPLC) using 4.6 mm × 25 cm columns (Beckman Instruments). Catecholamines were quantified by amperometric detection with 0.65 V Bioanalytical Systems electrode versus Ag/Ag reference electrodes.
renal function parameter assessment
Plasma and urinary sodium and creatinine values were used to assess renal function parameters. Glomerular filtration rate was estimated by creatinine clearance and tubular function by urinary sodium excretion.
renal tissue collection and processing
Immediately after sacrifice, both kidneys were removed from each animal and decapsulated. Sections of both kidneys were obtained and stored at -80ºC for western blot analyses and specific activity of Na+/K+-ATPase.
Protein expression analysis by western blot technique
Protein expression was semiquantitatively analyzed using western blot technique, as previously described. (22) Renal expression of Na+/K+-ATPase was determined using antiNa+/K+-ATPase antibody (Amersham, dilution 1: 8000), renal expression of NPRA, using anti-NPRA antibody (Santa Cruz Biotechnology, dilution 1: 7500), and expression of NPRC, using anti-NPRC antibody (Santa Cruz Biotechnology, dilution 1: 400). Biotinylated IgG anti-rabbit antibody (GE Healthcare Life Sciences, dilution 1: 2000) and streptavidin conjugated with radish peroxidase (GE Healthcare Life Sciences, dilution of 1: 2000) were used for secondary and tertiary reactions, respectively. The samples were revealed by chemiluminescence using ECL reagent (Amersham Pharmacia Biotech). The density of the bands was quantified with Image J software (RSB). Anti-GAPDH antibody was used as internal standard loading control (Santa Cruz Biotechnology, dilution 1: 1500).
na+/K+-aTPase specific activity analysis
Fifty mg samples of renal cortex were homogenized (1:10 weight/volume) in a solution containing 25 mM imidazole/1 mM EDTA/0.25 M sucrose and centrifuged at 4700 g at 4°C for 15 minutes. ATPase activity was measured by colorimetric determination of the released orthophosphate and ouabain was used to specifically inhibit the Na+/K+-ATPase activity according to Fiske-Subarrow's method, as previously described.
Statistical analysis
The data were processed with the GraphPad Prism program, version 2.0. Gaussian distribution was evaluated by the Kolmogorov and Smirnov method and ANOVA followed by Newman-Keuls or Tukey tests was used to compare between the groups, as appropriate. Results were expressed as mean±SEM. Results with p<0.05 were considered statistically significant.
ethical considerations
All the experiments were carried out in accordance with the ethical norms of international regulations and the principles of care and use of experimental animals (protocol approved by CICUAL with Res. CD 2100-15, EXP-UBA: 0035638/15). At the beginning of the study rats were randomly assigned to 2 groups: a control group (C) with ad libitum tap water and a fructose group (F) with fructose (at 10% W/V) in the ad libitum drinking water for 4, 8 and 12 weeks (n=8 rats per group and period).
RESULTS
Metabolic, hemodynamic and renal function parameters
Plasma insulin values were significantly increased by the high fructose diet compared with control rats since week 4 of treatment, indicating presence of hyperinsulinemia (Table 1) . Similarly, SBP values were significantly increased in the rats with high fructose diet compared with control rats since week 4 of treatment (Table 1 ). In the kidneys, fructose overload in the diet was associated with a significant increase in diuresis, as well as a reduction in sodium urinary excretion compared with control rats since week 4 of treatment (Table 1) . Creatinine clearance was not significantly modified by fructose treatment in any experimental period. The presence of microalbuminuria as a marker of renal damage was observed in week 12 of fructose treatment (Table 1) .
renal dopaminergic system
A significant reduction in urinary dopamine excretion together with an increase of L-dopa excretion was observed in rats with high fructose diet compared with the control groups since week 4 of treatment. These changes caused a significant increase in the L-dopa/ urinary dopamine ratio since the same week (Table  1) . A positive correlation was found between SBP and L-dopa/urinary dopamine ratio during the 12-week study period (R2=0.7816, p=0.002).
Specific activity and expression of renal na+/K+-aTPase
The specific activity of renal Na+/K+-ATPase was significantly increased since week 4 of fructose treatment with respect to control rats ( Table 1 ). The increase in activity was accompanied by an increase in protein expression by western blot (Figure 1 ).
anP system
A significant decrease in plasma ANP concentration was observed in rats with high fructose diet at weeks 8 and 12 of treatment ( Figure 2 ). In the kidneys, a decrease in NPRA expression was found since week 8 ( Figure 3 ) together with an increase in NPRC expression since week 4 of treatment ( Figure 4 ).
DISCUSSION
Metabolic syndrome is an entity that comprises a set of disorders or metabolic abnormalities considered risk factors for the development of diabetes and cardiovascular disease.
(1) It has been shown that rats fed a high fructose diet exhibit a large number of metabolic syndrome characteristics, such as insulin resistance, hyperinsulinemia and high blood pressure. (23) In our experiments, rats with a high fructose diet presented hyperinsulinemia, indicating the existence of insulin-resistance. The increase in SBP was detected after week 4 of fructose treatment and reached the highest blood pressure values at 8 and 12 weeks, with levels close to 160 mmHg. Systolic blood pressure levels were associated with a decrease in urinary sodium excretion since the same week, reflecting the state of saline retention in this experimental model. Although the exact mechanism by which hypertension develops in insulin-resistance conditions is still unknown, some studies suggest that hyperinsulinemia could cause sodium retention and an increase in sympathetic activity, key factors in the development of this disease. (24) Other authors suggest that the increase in renal reabsorption of sodium induced by insulin is enhanced Table 1 . Effects of fructose treatment on metabolic, hemodynamic and renal parameters at 4, 8 and 12 weeks of treatment in insulin resistance. Insulin stimulates all sodium transporters located in the proximal tubules, among them the Na+/K+-ATPase pump, the type 3 Na+/H+ exchanger (NHE3), and the electrogenic basolateral cotransporter Na+/HCO3-(NBCe1). (24) In our model, an increase in the specific activity of Na+/K+-ATPase enzyme was observed since week 4 of treatment, accompanied by an increase in its protein expression by western blot. These data are supported by other studies showing that Na+/K+-ATPase is stimulated in insulin-resistance conditions and chronic exposure of renal cells to increased plasma insulin, which leads to greater sodium and water reabsorption, and, therefore, greater saline retention. (25 A high fructose diet was associated with alterations in the natriuretic systems of renal dopamine and ANP. Regarding the renal dopaminergic system, a progressive increase in urinary L-dopa/ dopamine ratio was observed after week 4 of treatment, at the expense of an increase in the urinary excretion of Ldopa and a reduction of dopamine excretion. These changes would indicate the presence of reduced tubular uptake of L-dopa, a deficit of L-dopa conversion into dopamine in the tubular cells or a modification in the tubular release of the amine. In this sense, it has been shown that insulin stimulates the process of tubular L-dopa uptake and that this effect is abolished in rat models with insulin resistance due to fructose overload. (26) In another model of obesity-induced hyperinsulinemia, the presence of insulin resistance together with an increase in sympathetic tone was associated with lower renal dopaminergic activity. (27) The increase in urinary L-dopa/ dopamine ratio showed a positive correlation with the increase in SBP, thus being an adequate parameter that accompanies the increase in blood pressure levels in this model. Conversely, the ANP plasma concentration was significantly reduced since week 8 in rats with fructose overload, accompanied by a decrease in NPRA receptor expression. These results are consistent with the literature, where an association between low ANP levels, reduction in NPRA expression and states of insulin-resistance has been demonstrated. (16, 17, 28) A possible explanation for the reduction in plasma ANP concentration would be an increase in its degradation by NPRC receptors. In our study, NPRC expression was increased in the kidneys. In models of obesity and insulin resistance, the increased levels of NPRC described in adipose tissue would be responsible for the reduction of natriuretic peptide plasma levels in these conditions. (28) Likewise, the alteration of both natriuretic systems preceded in time the presence of microalbuminuria as a marker of renal structural damage in week 12; therefore, it can be postulated that the alteration of these systems would be associated with damage in this organ. Regarding this point, it has been described that renal dopamine regulates the inflammatory and oxidative condition through its D2 receptors, with an increase in proinflammatory and oxidative stress markers in models with receptor deficiency. (29) Additionally, it has been shown that ANP has antioxidant effects in rats by attenuating the levels of reactive oxygen species in a model of renal damage by ischemia-reperfusion. (30) Our laboratory has shown that ANP stimulates dopamine uptake by tubular kidney cells, through the stimulation of NPRA receptors and protein kinase G (PKG) activation. (11, 12, 22) Moreover, it has been shown that ANP increases the synthesis of renal dopamine by stimulating the activity of dopa decarboxylase. (31) In this insulin-resistance model, and as a result of low levels of plasma ANP, a reduction in both synthesis and uptake of dopamine by tubular cells would be expected as a consequence of reduced 
